Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2022
/
Article
/
Tab 4
/
Research Article
Application of Arsenic Trioxide-Based Combined Sequential Chemotherapy in Recurrent Resistant and Refractory Ovarian Cancers: A Single-Center, Open Phase II Clinical Study
Table 4
Possible treatment-related adverse events in the safety population.
Adverse event
Any grade
Grades 3 to 4
Any adverse event
No
%
No
%
Marrow suppression
33
100%
24
73%
Anemia
28
85%
4
12%
Neutropenia
33
100%
23
70%
Thrombocytopenia
12
36%
1
3%
Drug-induced liver injury
6
18%
0
0
Pyrexia
6
18%
0
0
Diarrhea
2
6%
0
0
Nausea
1
3%
0
0
Vomiting
1
3%
0
0
Abdominal pain
1
3%
0
0
Constipation
1
3%
0
0
Abdominal distension
1
3%
0
0
Mucositis/stomatitis
1
3%
0
0
Abdominal pain, upper
1
3%
0
0
Peripheral neuropathy
1
3%
0
0
Rash
1
3%
0
0